TREATMENT OF CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE

• 收藏
• 分享

专利权人:

Eli Lilly and Company

发明人:

Sau-Chi Betty YAN

申请号：

US16345866

公开号：

US20200054616A1

申请日:

2017.11.09

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention provides a method of treating cancer with tumors bearing MET exon 14 skipping or MET exon 14 skipping phenotype comprising administering to a patient in need of such treatment an effective amount of the compound of Formula (I), or a pharmaceutically acceptable salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/